The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
Authors
Keywords
Cirrhosis, Alcoholics, Portal hypertension, Macrophages, Hepatitis, Liver diseases, Alcoholic liver disease, Kupffer cells
Journal
PLoS One
Volume 12, Issue 12, Pages e0189345
Publisher
Public Library of Science (PLoS)
Online
2017-12-14
DOI
10.1371/journal.pone.0189345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis
- (2016) T. D. Sandahl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
- (2016) Henning Grønbæk et al. JOURNAL OF HEPATOLOGY
- The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
- (2015) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival
- (2015) Sidsel Rødgaard-Hansen et al. Infectious Diseases
- Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study
- (2014) Thomas Damgaard Sandahl et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
- (2014) Anders G. Kjærgaard et al. PLoS One
- Targeting Dexamethasone to Macrophages in a Porcine Endotoxemic Model
- (2013) Asger Granfeldt et al. CRITICAL CARE MEDICINE
- Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study
- (2013) E. S. Andersen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Hepatic macrophage activation predicts clinical decompensation in chronic liver disease
- (2013) Anthony Rode et al. GUT
- Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
- (2012) H. Grønbaek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The mannose receptor
- (2012) Luisa Martinez-Pomares JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
- (2012) Jonas H Graversen et al. MOLECULAR THERAPY
- Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
- (2011) P. Holland-Fischer et al. GUT
- Increased Interleukin 21 (IL-21) and IL-23 Are Associated with Increased Disease Activity and with Radiographic Status in Patients with Early Rheumatoid Arthritis
- (2010) T. K. RASMUSSEN et al. JOURNAL OF RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation